Tag: apricus biosciences

Ligand Partner Seelos Therapeutics Becomes a Public Company

Ligand Pharmaceuticals (NASDAQ:LGND) partner Seelos Therapeutics (NASDAQ:SEEL) announced that it has closed a reverse merger with Apricus Biosciences. As quoted in...

Seelos Therapeutics Announces Successful Completion of its Merger with Apricus Biosciences

Seelos Therapeutics (Nasdaq:SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical...

Apricus Biosciences and Seelos Therapeutics Announce Merger

Once the merger is completed, the merged company will be called Seelos Therapeutics and will begin trading on the NASDAQ...

Apricus Biosciences Announces Merger Agreement with Seelos Therapeutics

Apricus Biosciences (NASDAQ:APRI) has announced it has signed an agreement to merge with Seelos Therapeutics in an all-stock transaction. As...